CAS: 13939-69-0; 1-Piperidinecarbonylchloride

该化合物是一种多用途有机化合物,主要用作合成化学反应中间体,其管状碳基结构对将管状动物引入目标分子,特别是制药和农用化学应用中具有价值.该化合物对氨酰胺和酒精等核素具有高度反应性,有助于在温和条件下高效的氨化和酯形成.它经常用于联反应和热循环合成.氯化物组增强了其电益特性,能够进行选择性转化.适当的处理由于其湿度敏感度和潜在的腐蚀性而必不可少.这种试剂通常在惰性条件下使用,以确保最佳的稳定性和反应性能.

结构式图片

相似化合物

2591-86-8 1440-60-4 618-42-8

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

piperidine phosgene 2-oxo-2-(piperidin-1-yl)acetic acid carbon dioxide 1-(aziridine-1-carbonyl)-piperidine piperidine-1-carboxylic acid methyl ester piperidine-1-carboxylic acid benzo[1,3]dioxol-5-yl ester S-Ethyl-N,N-pentamethylen-thi°Carbamat

合成工艺路线路线简述

    📜二环戊亚甲基二硫化四烷基秋兰姆置于氯,水,碳酸氢钠体系中,用 二氯甲烷 用作溶剂,化学反应 7.83H,以85.6%的收率获得1-哌啶酰氯
    参考文献:开发一种将秋兰姆二硫化物转化为 N,N-二烷基氨基甲酰基卤化物和衍生物的改进方法
    标题:开发一种将秋兰姆二硫化物转化为 N,N-二烷基氨基甲酰基卤化物和衍生物的改进方法
    摘要:报道了一种制备 N,N-二取代氨基甲酰卤的简便方法.它由两个步骤组成:(1)二硫化碳和仲胺在极性有机溶剂和氧气存在下反应生成相应的四烷基秋兰姆二硫化物和(2)四烷基秋兰姆与卤化物在一种非质子有机溶剂,可产生相应的 N,N-二取代氨基甲酰卤.
    Doi:10.1080/00397910903537331

    海关参考信息

    专利信息


    专利号:US-11655255-B2
    优先权日:2022-10-17
    标题 :Method for catalytic asymmetric synthesis of phosphorus-stereogenic (P-stereogenic) nucleoside derivative and catalyst used therein
    发明人:ZHANG WANBIN; WANG MO; ZHANG LU; HUO XIAOHONG; ZHANG ZHENFENG; YUAN QIANJIA; CHEN JIANZHONG
    权利人:SPH NO 1 BIOCHEMICAL & PHARMACEUTICAL CO LTD; UNIV SHANGHAI JIAOTONG
    摘要:A method for catalytic asymmetric synthesis of a phosphorus-stereogenic (P-stereogenic) nucleoside derivative of formula (3) and a catalyst used therein. The P-stereogenic nucleoside derivative (3) can be hydrolyzed to obtain remdesivir. Specifically, a nucleoside and phosphoryl chloride are subjected to asymmetric reaction under the catalysis of a chiral bicyclic imidazole catalyst in the presence of a base to produce the P-stereogenic nucleoside derivative of formula (3)

    专利号:US-2022281888-A1
    优先权日:2019-09-25
    标题:Bicyclic carboxylates as modulators of transporters and uses thereof
    发明人:SANDANAYAKA VINCENT; GORECZNY GREGORY
    权利人:NIROGY THERAPEUTICS INC
    摘要:The present invention generally relates to the field of transporter modulators, e.g., monocarboxylate transporter inhibitors, and more particularly to new bicyclic enone carboxylate compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with monocarboxylate transporter activity such as in treating cancer and other neoplastic disorders, tissue and organ transplant rejection.

    专利号:US-2023085986-A1
    优先权日:2022-10-17
    标 题:Method for catalytic asymmetric synthesis of phosphorus-stereogenic (p-stereogenic) nucleoside derivative and catalyst used therein

    专利号:CN-113754692-A
    优先权日:2020-06-03
    标题 :Asymmetric catalytic synthesis method of Ruideciclovir intermediate (S, S) -phosphoramidate

    专利号:CN-113754693-B
    优先权日:2020-06-03
    标 题 :Asymmetric catalytic synthesis method and catalyst of phosphorus chiral nucleoside derivative

    专利号:CN-113754693-A
    优先权日:2020-06-03
    标题:Asymmetric catalytic synthesis method and catalyst of phosphochiral nucleoside derivatives

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Aitken, R. A.; Boubalouta, Y., Science of Synthesis Knowledge Updates, (2013) 4, 156.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知